Beta-lactam-resistant Staphylococcus aureus in infections detected in the community
DOI:
https://doi.org/10.35954/SM2006.28.1.3Keywords:
Community-acquired infections; Staphylococcal infections; Antibiotic resistance; Methicillin resistance.Abstract
The aim of this study was to determine the proportion of community methicillin-resistant Staphylococcus aureus isolates in samples from skin, soft tissue and blood infections, their evolution over time and their sensitivity to antibiotics.
A retrospective study of the results of bacteriological analyses, performed between January 2001 and August 2004, in the Microbiology Service of the HCFFAA was carried out. The frequency of Staphylococcus aureus is 98% for boils, abscesses and hidradenitis; being 82% SAMR-com. In ulcers, eschar and skin lesions other than the above, the proportion of SAMR-com is 25%. In blood it has been isolated since 2002. More than 45% of isolates are resistant to erythromycin and 98% of these have inducible resistance to clindamycin. In recent months, SAMR-com resistant to gentamicin has been detected.
Downloads
References
(1) TAMMY L. BANNERMAN. Staphylococcus, Micrococus and other catalasa positive cocci that grow aerobically. In: Manual of Clinical Microbiology. Patrick R. Murray, E.J. Baron, J.H. Jorgesen, M.A. Faller, R.H. Yolken. 8va edición, 2003, editado por la Asociación Americana de Microbiología.
(2) MORTON N. SWARTZ. Infecciones de la piel y de los tejidos blandos. En: Mandell G., Douglas RG, Bennett J.E,. Enfermedades infecciosas. Principio y prácticas., 3ra. ed. , 1990, Editorial Panamericana.
(3) HENRY F. CHAMBERS. (1997) Methicillin resistance in Staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 10(4), 781-791.
(4) KATAYAMA Y, ITO T AND HIRAMATSU K.(2000) A new class of genetic element, staphylococcus casette chromosome mec, encodes methicillin-resistance in Staphylococcus aureus. Antimicrob. Agents Chemotheer. 44, 1549-1555.
(5) HALEY RW, HIGHTOWER AW, KHABBATZ RF, THORNSBERRY C, MARTONE WJ, ALLEN JR AND HUGHS JM. (1982) The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Annn. Intern. Med. 97, 297-308
(6) OLIVEIRA DC, TOMASZ A AND LENCASTRE H.(2002) Secrets of success of human pathogens: molecular evolution of pandemis clones of methicillin-resistant Staphylococcus aureus. Lancet Infect. Dis. 2, 180-189.
(7) AIRES DE SOUSA M, MIRAGAIA M, SANCHES IS, AVILA S, ADAMSON I, CASAGRANDE ST, BRANDILEONE MC, PALACIO R, DELL'ACQUA L, HORTAL M, CAMOU T, ROSSI A, VELAZQUEZ-MEZA ME, ECHANIZ-AVILES G, SOLORZANO-SANTOS F, HEITMANN I, DE LENCASTRE H. (2001) Three-year assessment of methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998. J Clin Microbiol. 39(6):2197-205.
(8) UDO EE, PEARMAN JW AND GRUBB WB.(1993) Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J. Hosp. Infect. 25,97-108
(9) CDC Center for Disease Control (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minesota and North Dakota 1997-1999. Morbid. Mortal. Wkly. Rep. 48, 707-710.
(10) MAGUIRRE GP, ARTHUR AD, BONSTEAD PJ, DWYER D AND CURRIE BJ. (1988) Clinical experience and outcmes of community acquired and nosocomial methicillin-resistant Staphylococcus aureus in northen Australian Hospital. J. Hosp. Infect. 38, 273-281.
(11) AIRES DE SOUSA M AND LENCASTRE H.(2003) Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community acquired MRSA. J. Clin. Microbio. 41, 3806-3815.
(12) DUFOUR P, GILLET Y, BES M, LINA G, VANDEBESCH F, FLORET D, ETIENNE J, AND RICHET H. (2002) Community-acquired methicillin resistant Staphylococcus aureus infections in France: emergency of a single clone that produces Pantom-Valentine leukocidin. Clin. Infect. Dis. 35, 819-824.
(13) O BRIEN FG, PEARMAN JW, GRACEY M, RELEY TV AND GRUBB WB (1999) Community strain of methicillin-resistant Saphylococcus aureus involved in hospital outbreak. J. Clin. Microbiol. 37, 2858-2862.
(14) PEDREIRA W, GALIANA A. (2004) Una nueva clona de Staphylococcus aureus con resistencia a meticilina y alta virulencia emergente en la comunidad y en los grandes hospitales en Uruguay. http://www.smu.org.uy/emc/novedades/samr/galiana.pdf
(15) MSP. (2004)Noticias. http://msp.gub.uy/saludpoblacion/bacteria.htm.
(16) ALGORTA G. (2004) Métodos de estudio de la sensibilidad de S. aureus. http://www.smu.org.uy/emc/novedades/samr/camrsa-4.pdf
(17) NABÓN A, DIANESSI M, RANGONI P, SPARKEZ C, SQUARZA G, CASTRO M, CHAGAS R, CHANG HJ, DE VECCHI P, CARBALLO D, DOUTON A, BORTHAGARAY G (1997) Frecuencia de multiresistencia a antibióticos en Staphylococcus sp. 1er. Congreso Uruguayo de Bioquímica Clínica, Montevideo
(18) NABON A, BORTHAGARAY G, (1999) Variaciones temporales en los patrones de resistencia de Staphylococcus aureus. 2do. Congreso Uruguayo de Bioquímica Clínica, Montevideo
(19) SAVIO E (2004) Consideraciones clínicas y directivas terapéuticas en las enfermedades producidas por SAMR-com. Dirección General de la Salud, Ministerio de Salud Pública.
(20) ISENBERG HD. (1992) Clinical Microbiology Procedures Handbook, Editado por la Asociación Americana de Microbiología
(21) National Committe for Clinical Laboratory Standards (2004) Performance standard for antimicrobial disk susceptibility test, M100-S14.
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
